Skip to main content
Clinical Trials/IRCT20180122038472N2
IRCT20180122038472N2CompletedPhase 3

The effects of Nigella sativa oil supplement on serum systemic inflammatory and oxidative stress markers and lipid profiles in dialysis patients: double-blind clinical trial

Sabzevar University of Medical Sciences0 sites55 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
55

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
45 years to 75 years (—)
Sex
All

Inclusion Criteria

  • The study subjects were being dialyzed with polysulfone capillary dialyzers 3 times a week for 4 h per session
  • The study, the hemodialysis procedure and type of dialyzer were not altered
  • Must be able to swallow capsules

Exclusion Criteria

  • infectious diseases especially hepatitis
  • patients taking Nigella sativa
  • patients taking omega-3 fatty acid supplements, L-carnitine
  • patients taking vitamin E and/or C supplements
  • patients taking steroidal and/or non-steroidal anti-inflammatory drugs.

Investigators

Sponsor
Sabzevar University of Medical Sciences

Similar Trials